Article
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute - 4 Dec 2002
Narod Steven A, Dubé Marie-Pierre, Klijn Jan, Lubinski Jan, Lynch Henry T, Ghadirian Parviz, Provencher Diane, Heimdal Ketil, Moller Pal, Robson Mark, Offit Kenneth, Isaacs Claudine, Weber Barbara, Friedman Eitan, Gershoni-Baruch Ruth, Rennert Gad, Pasini Barbara, Wagner Theresa, Daly Mary, Garber Judy E, Neuhausen Susan L, Ainsworth Peter, Olsson Hakan, Evans Gareth, Osborne Michael, Couch Fergus, Foulkes William D, Warner Ellen, Kim-Sing Charmaine, Olopade Olufunmilayo, Tung Nadine, Saal Howard M, Weitzel Jeffrey, Merajver Sofia, Gauthier-Villars Marion, Jernstrom Helena, Sun Ping, Brunet Jean-Sebastien
Abstract excerpt
BACKGROUND: Oral contraceptive use has been associated with an increase in the risk of breast cancer in young women. We examined whether this association is seen in women at high risk of breast cancer because they carry a mutation in one of two breast cancer susceptibility genes, BRCA1 and BRCA2....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.